Gyre Therapeutics (GYRE) Short term Debt (2010 - 2016)
Gyre Therapeutics (GYRE) reported Short term Debt of $28000.0 for Q3 2016, down 95.86% year-over-year from $676000.0 in Q4 2015, and down 78.46% on a QoQ basis from $130000.0 in Q2 2016.
Gyre Therapeutics (GYRE) has 7 years of Short term Debt data on file, last reported at $28000.0 in Q3 2016.
- Quarterly Short term Debt fell 95.86% year-over-year to $28000.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $28000.0 (down 95.86% YoY) and the FY2015 annual result came in at $1.2 million, changed N/A from the prior year.
- Short term Debt slipped to $28000.0 in Q3 2016 per GYRE's latest filing, from $130000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $1.2 million in Q4 2015 and bottomed at $28000.0 in Q3 2016.
- The 5-year median for Short term Debt is $847500.0 (2012), against an average of $690625.0.
- The widest annual swing landed in 2015, when Short term Debt surged 41.42%; it then tumbled 95.86% in 2016.
- Tracing GYRE's Short term Debt over 5 years: stood at $851000.0 in 2012, then grew by 0.24% to $853000.0 in 2013, then plunged by 43.96% to $478000.0 in 2014, then jumped by 141.84% to $1.2 million in 2015, then plunged by 97.58% to $28000.0 in 2016.
- Per Business Quant, the three latest GYRE Short term Debt figures stand at $28000.0 (Q3 2016), $130000.0 (Q2 2016), and $196000.0 (Q1 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 28,000.00 |
| Jun 30, 2016 | 130,000.00 |
| Mar 31, 2016 | 196,000.00 |
| Dec 31, 2015 | 1.16 Mn |
| Sep 30, 2015 | 676,000.00 |
| Sep 30, 2014 | 478,000.00 |
| Jun 30, 2014 | 699,000.00 |
| Mar 31, 2014 | 776,000.00 |
| Dec 31, 2013 | 853,000.00 |
| Sep 30, 2013 | 873,000.00 |
| Jun 30, 2013 | 866,000.00 |
| Mar 31, 2013 | 858,000.00 |
| Dec 31, 2012 | 851,000.00 |
| Sep 30, 2012 | 844,000.00 |
| Jun 30, 2012 | 870,000.00 |
| Mar 31, 2012 | 896,000.00 |
| Dec 31, 2011 | 1.24 Mn |
| Sep 30, 2011 | 1.59 Mn |
| Jun 30, 2011 | 1.91 Mn |
| Dec 31, 2010 | 1.71 Mn |